QuatCy-I2 and MHI-I2 in Photodynamic Therapy
- PMID: 35300076
- PMCID: PMC8919274
- DOI: 10.1021/acsmedchemlett.1c00640
QuatCy-I2 and MHI-I2 in Photodynamic Therapy
Abstract
MHI-I2 (1) and QuatCy-I2 (2) were compared in terms of properties important for early-stage photodynamic therapy preclinical candidates. Thus, experiments were performed to monitor dark cytotoxicities, light/dark cytotoxicity ratios, selectivity of localization in tumors over other organs, and clearance from the plasma.
© 2022 American Chemical Society.
Conflict of interest statement
The authors declare no competing financial interest.
Figures




Similar articles
-
Protein labelling and albumin binding characteristics of the near-IR Cy7 fluorophore, QuatCy.Org Biomol Chem. 2019 Aug 14;17(30):7150-7154. doi: 10.1039/c9ob01184f. Epub 2019 Jul 18. Org Biomol Chem. 2019. PMID: 31317168 Free PMC article.
-
QuatCy: A Heptamethine Cyanine Modification With Improved Characteristics.Theranostics. 2019 Apr 13;9(10):2856-2867. doi: 10.7150/thno.33595. eCollection 2019. Theranostics. 2019. PMID: 31244928 Free PMC article.
-
Efficacy of Photodynamic Therapy for the Treatment of Bowen's Disease: A Meta-Analysis of Randomized Controlled Trials.Dermatology. 2022;238(3):542-550. doi: 10.1159/000519319. Epub 2021 Oct 15. Dermatology. 2022. PMID: 34657035
-
High cut-off membranes in patients requiring renal replacement therapy: a systematic review and meta-analysis.Chin Med J (Engl). 2023 Jan 5;136(1):34-44. doi: 10.1097/CM9.0000000000002150. Chin Med J (Engl). 2023. PMID: 36848147 Free PMC article.
-
Hypericin in the Light and in the Dark: Two Sides of the Same Coin.Front Plant Sci. 2016 May 6;7:560. doi: 10.3389/fpls.2016.00560. eCollection 2016. Front Plant Sci. 2016. PMID: 27200034 Free PMC article. Review.
Cited by
-
Cytotoxicities of Tumor-Seeking Dyes: Impact on Future Clinical Trials.ChemMedChem. 2023 Mar 1;18(5):e202200561. doi: 10.1002/cmdc.202200561. Epub 2023 Jan 26. ChemMedChem. 2023. PMID: 36630600 Free PMC article.
-
Tissue-seeking dyes for in vivo applications.Smart Mol. 2024 Oct 24;2(4):e20240029. doi: 10.1002/smo.20240029. eCollection 2024 Dec. Smart Mol. 2024. PMID: 40626275 Free PMC article. Review.
References
-
- Cheng P. H.; Pu K. Y. Molecular imaging and disease theranostics with renal-clearable optical agents. Nat. Rev. Mater. 2021, 6, 1095–1113. 10.1038/s41578-021-00328-6. - DOI
Grants and funding
LinkOut - more resources
Full Text Sources